ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer
For patients with PD-L1 combined positive score of ≥10, pembrolizumab prolongs overall survival
FDA Takes Hard Look at CBD
CBD products have swamped the market due to change in federal law, not because of new medical evidence
Many Buprenorphine Prescribers Not Offering New Appointments
However, for those offering new appointments, wait times were not long to receive buprenorphine
Excess Cause-Specific Mortality Tied to Chronic Proton Pump Inhibitor Use
Excess mortality due to CVD, CKD, upper GI cancer for those with no indication for PPI use
Providers, Peers Influence Aspirin Use Among African-Americans
Positive social environment around a prevention approach may increase uptake, authors say
FDA to Hold First Public Meeting on CBD
Scheduled speakers will include doctors, consumers, and cannabis industry members
Noncompliance Common in Teens Prescribed STI Treatment in ED
Prescriptions often go unfilled; hospital admission is the only factor associated with prescription filling
Esketamine Nasal Spray May Improve Refractory Depression Outcomes
Findings seen among outpatients with treatment-resistant depression using combo nasal spray, oral antidepressant
More Opioids Given Than Prescribed in Emergency Department
Opioids more often given in ED than prescribed at discharge for adult ED visits
Recommendations Developed for Pediatric Multiple Sclerosis Trials
Biological rationale exists for using treatments proven efficacious in adults with MS for pediatric MS
